Overview

Study to Compare Pharmacokinetic Property of SYO-1644 Tab. and Nexavar Tab. in Healthy Male Volunteers

Status:
Completed
Trial end date:
2019-07-23
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pharmacokinetics characteristics ,tolerability, and safety after orally administrating SYO-1644 to healthy male volunteers in randomized, active-controlled, open-label clinical study.
Phase:
Phase 1
Details
Lead Sponsor:
Samyang Biopharmaceuticals Corporation
Collaborator:
Seoul National University Hospital
Treatments:
Sorafenib